Skip to main content
. 2022 Feb 18;322(4):H647–H680. doi: 10.1152/ajpheart.00674.2021

Figure 3.

Figure 3.

Allogeneic vs. autologous stem cell therapeutic strategies in differing patient populations. The advantages and disadvantages of allogeneic (shelf) stem cell therapies are shown with attention paid to donor sex differences (A). For the autologous (self) strategy, effectiveness of stem cell therapies are shown in “ideal” recipients as well as various patient populations such as obesity, smoking, atherosclerosis, diabetes, and aging (B). Image created with BioRender.com. HGF, hepatocyte growth factor; SDF-1, stromal cell derived factor-1; VEGF, vascular endothelial growth factor.